Australian swimming stars Cate and Bronte Campbell at Bondi Beach. Picture: Gregg PorteousSWIMMING champion Cate Campbell is on the hunt for a new home.Sister Bronte moved out of their Bowen Hills apartment in December to Coorparoo, and Cate’s looking to follow although is extending her house search area to Morningside and Hawthorne.“I’m looking for a bit of greenery after being in an apartment for three years and right next to train tracks and a main road,” Cate said.The plan is to buy a large house which friends can share. Cate and Bronte Campbell. Picture: Julie Kiriacoudis“I love living by myself but I can see myself turning into a hermit so I’ll have friends rent rooms off me,” Cate said.More from newsMould, age, not enough to stop 17 bidders fighting for this home3 hours agoBuyers ‘crazy’ not to take govt freebies, says 28-yr-old investor9 hours ago“And probably do most of the gardening. “I enjoy the outdoors but I’m a terrible green thumb.”A pool is not on Cate’s list of property must-haves.“I spent so much time in the pool it’s not something I’m rally keen on having,” she said.“I wouldn’t use it but friends are keen on me having a pool so it’s not a deal breaker.“I would be open to a spa though.”Shannon Harvey, from Place Estate Agents Bulimba, is assisting Cate in her search.It’s not the first time Ms Harvey has helped a high-profile athlete hunt for a home.“I’m currently working with a Reds player on a house but no permission to reveal who,” she said.“I have worked with a few Reds players, Firebirds players, Lions players and coaches, and the Suns coach.”
Share HealthInternationalLifestylePrint Johnson & Johnson fined $1.1bn in latest Risperdal case by: – April 11, 2012 Sharing is caring! Johnson & Johnson is appealing fines handed down by other US statesDrugs giant Johnson & Johnson (J&J) has been ordered by a US judge to pay $1.1bn (£690m) for downplaying the risks involved in taking its anti-psychotic drug Risperdal.The state of Arkansas sued J&J and its subsidiary Janssen Pharmaceuticals over its marketing of the drug in 2007.A number of US states have already found the firms guilty of similar charges and fined them accordingly.Janssen said it was “disappointed” with the judge’s decision.The company added that if its motion for a retrial was denied, it would appeal the fine.“During the nearly three-week trial, Janssen presented abundant evidence showing the company acted responsibly and fully complied with all laws and regulations regarding Risperdal,” it said in a written statement.AppealIn January, J&J agreed to pay $158m to settle allegations of illegal marketing of Risperdal in Texas.Last year, a South Carolina judge ruled the company must pay a $327m penalty after a jury found it guilty of similar charges, while in 2010, a Louisiana jury found the company violated the state’s Medicaid fraud act.These two verdicts are currently under appeal.Medicaid is a government-backed US public heath programme for low-income citizens.BBC News 12 Views no discussions Share Tweet Share
The content of this field is kept private and will not be shown publicly.